Cancer Stem Cells, Endothelial Progenitors, and Mesenchymal Stem Cells: "seed and Soil" Theory Revisited

Overview

Journal Gastrointest Cancer Res

Date 2009 Mar 5

PMID 19259284

Citations 13

Authors

Edward H Lin

Yixing Jiang

Yanhong Deng

Ritu Lapsiwala

Tongyu Lin

C Anthony Blau

Affiliations

Soon will be listed here.

Abstract

Isolation of putative cancer stem cells (CSCs) in various tumors has generated much excitement among researchers who consider these cells the potential "culprits" behind resistance to conventional therapy. Both cancer and cardiovascular disease are believed to be stem cell disorders involving circulating endothelial progenitors (CEPs) and mesenchymal stem cells (MSCs). CD133 and CD44, markers of CSCs in many tumors, also enrich CEPs and MSCs, respectively. We propose an integrated tumorigenesis model that involves all three interdependent stem cell (CSC, CEP, MSC) compartments by revisiting the "seed and soil" model. Developing therapeutics that can effectively target CSCs and spare normal cardiovascular tissue will remain a challenge. Preliminary laboratory and clinical data on monitoring and targeting colon CSCs, using such a modeling system, are discussed.

Citing Articles

Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case.

Mathews A, Shelton W, Santos Horta E, Reddy Damalcheruvu P, Nix J, Gokden M J Neurosurg Case Lessons. 2024; 7(7).

PMID: 38346299 PMC: 10865468. DOI: 10.3171/CASE23679.

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Ranjan T, Sengupta S, Glantz M, Green R, Yu A, Aregawi D Cell Rep Med. 2023; 4(5):101025.

PMID: 37137304 PMC: 10213810. DOI: 10.1016/j.xcrm.2023.101025.

microRNA-26a represses pancreatic cancer cell malignant behaviors by targeting E2F7.

Wang L, Li M, Chen F Discov Oncol. 2022; 12(1):55.

PMID: 35201478 PMC: 8777553. DOI: 10.1007/s12672-021-00448-z.

The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.

Saif M, Rajagopal S, Caplain J, Goodman M, Popowich D, Orkin B Cancer Med J. 2021; 4(Suppl 4):1-10.

PMID: 34368808 PMC: 8336105.

Mesenchymal stem cells maintain the stemness of colon cancer stem cells via interleukin-8/mitogen-activated protein kinase signaling pathway.

Ma X, Liu J, Yang X, Fang K, Zheng P, Liang X Exp Biol Med (Maywood). 2020; 245(6):562-575.

PMID: 32122165 PMC: 7158600. DOI: 10.1177/1535370220910690.

References

Hanai J, Gloy J, Karumanchi S, Kale S, Tang J, Hu G . Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol. 2002; 158(3):529-39. PMC: 2173844. DOI: 10.1083/jcb.200203064. View

Colleselli D, Bijuklic K, Mosheimer B, Kahler C . Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res. 2006; 312(15):2933-41. DOI: 10.1016/j.yexcr.2006.05.021. View

Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

Houghton J, Stoicov C, Nomura S, Rogers A, Carlson J, Li H . Gastric cancer originating from bone marrow-derived cells. Science. 2004; 306(5701):1568-71. DOI: 10.1126/science.1099513. View

Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C . Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer. 2007; 43(5):935-46. DOI: 10.1016/j.ejca.2007.01.017. View

Lou H, Dean M . Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene. 2007; 26(9):1357-60. DOI: 10.1038/sj.onc.1210200. View

Lin E, Curley S, Crane C, Feig B, Skibber J, Delcos M . Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?. Am J Clin Oncol. 2006; 29(3):232-9. DOI: 10.1097/01.coc.0000217818.07962.67. View

Jin L, Hope K, Zhai Q, Smadja-Joffe F, Dick J . Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12(10):1167-74. DOI: 10.1038/nm1483. View

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

10.

Bruno S, Bussolati B, Grange C, Collino F, Graziano M, Ferrando U . CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol. 2006; 169(6):2223-35. PMC: 1762463. DOI: 10.2353/ajpath.2006.060498. View

11.

Shaked Y, Ciarrocchi A, Franco M, Lee C, Man S, Cheung A . Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science. 2006; 313(5794):1785-7. DOI: 10.1126/science.1127592. View

12.

Li H, Stoicov C, Rogers A, Houghton J . Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol. 2006; 12(3):363-71. PMC: 4066053. DOI: 10.3748/wjg.v12.i3.363. View

13.

Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y . CD44 in cancer. Crit Rev Clin Lab Sci. 2002; 39(6):527-79. DOI: 10.1080/10408360290795574. View

14.

Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

15.

Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M . Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 2007; 67(5):2187-96. PMC: 3073370. DOI: 10.1158/0008-5472.CAN-06-3281. View

16.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

17.

Lindvall C, Bu W, Williams B, Li Y . Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev. 2007; 3(2):157-68. DOI: 10.1007/s12015-007-0025-3. View

18.

Buchanan F, DuBois R . Connecting COX-2 and Wnt in cancer. Cancer Cell. 2006; 9(1):6-8. DOI: 10.1016/j.ccr.2005.12.029. View

19.

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View

20.

Seigel G, Hackam A, Ganguly A, Mandell L, Gonzalez-Fernandez F . Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007; 13:823-32. PMC: 2768758. View